# Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice

> **NCT02322008** · — · COMPLETED · sponsor: **Regionshospitalet Viborg, Skive** · enrollment: 1035 (actual)

## Conditions studied

- Crohn's Disease
- Ulcerative Colitis
- Inflammatory Bowel Disease

## Interventions

- **BIOLOGICAL:** infliximab and adalimumab

## Key facts

- **NCT ID:** NCT02322008
- **Lead sponsor:** Regionshospitalet Viborg, Skive
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1035 (ACTUAL)
- **Last updated:** 2014-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02322008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02322008, "Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02322008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*